Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal (CPT-R-Nepal)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04570982

Recruitment Status : Unknown

Verified September 2020 by Dr. Pradip Gyanwali,MD, Nepal Health Research Council.
Recruitment status was: Recruiting

First Posted : September 30, 2020

Last Update Posted : September 30, 2020

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Ministry of Health and Population, Nepal

Information provided by (Responsible Party):

Dr. Pradip Gyanwali,MD, Nepal Health Research Council

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	October 30, 2020
Estimated Study Completion Date :	December 30, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Koirala J, Gyanwali P, Gerzoff RB, Bhattarai S, Nepal B, Manandhar R, Jha R, Sharma S, Sharma YR, Bastola A, Murphy H, Acharya S, Adhikari P, Rajkarnikari M, Vaidya KM, Panthi CL, Bista B, Giri G, Aryal S, Pant S, Pokharel A, Karki S, Basnet S, Koirala B, Dhimal M; Nepal COVID-19 Clinical Study Collaborators. Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study. Open Forum Infect Dis. 2021 Aug 21;8(8):ofab391. doi: 10.1093/ofid/ofab391. eCollection 2021 Aug.

To Top